The fight against the deadly tropical disease Leishmaniasis, also known as black fever, has been boosted by scientists at the University of Durham, whose new screening system has raised the possibility of new, safer drugs.
Livestock producers in the United States should be cautious but not overly fearful of bluetongue virus, according to a veterinary laboratory director at Kansas State University.
Patients who undergo liver transplantation at age 60 or above have one-year and five-year survival rates similar to those of younger patients and they experience fewer episodes of rejection.
The routine vaccination of children against Human Papilloma Virus (HPV) – the first adolescent vaccine against a sexually transmitted infection – will be discussed at the National Cancer Research Institute conference in Birmingham today (1515hrs, Tuesday 2 October).
New York State Agriculture Commissioner Patrick Hooker and New York State Health Commissioner Richard F. Daines, M.D. warned consumers that the previous alert, issued on Tuesday_September_25, has been expanded for Topps 100% Ground Beef Hamburgers due to possible contamination with E. coli 0157:H7.
Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,092,031 Phase II Small Business Innovation Grant (SBIR) from the National Eye Institute of the National Institutes of Health (NIH) to develop zebrafish eye disease models for drug screening. The grant for “New Models for Eye Diseases” will support the Phylonix program over a period of three years.
Extremely low birth weight premature infants who received breast milk shortly after birth, while still in intensive care units, had greater mental development scores at 30 months than did infants who were not fed breast milk, reported researchers in an NIH network. Moreover, infants fed breast milk were less likely to have been re-hospitalized after their initial discharge than were the infants not fed breast milk.
The American College of Physicians and the American Pain Society today released joint guidelines on diagnosing and treating low back pain.
One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.
Infection with West Nile Virus (WNV) can cause lethal encephalitis and there are currently no vaccines or specific therapeutics for use in humans. However, data generated by Erol Fikrig and colleagues at Yale University School of Medicine has provided evidence that the proinflammatory soluble factor MIF might provide a target for developing therapeutics to treat WNV encephalitis.